Clinical significance of abnormal electrocardiographic patterns in trained athletes.

BACKGROUND-The prevalence, clinical significance, and determinants of abnormal ECG patterns in trained athletes remain largely unresolved. METHODS AND RESULTS-We compared ECG patterns with cardiac morphology (as assessed by echocardiography) in 1005 consecutive athletes (aged 24+/-6 years; 75% male) who were participating in 38 sporting disciplines. ECG patterns were distinctly abnormal in 145 athletes (14%), mildly abnormal in 257 (26%), and normal or with minor alterations in 603 (60%). Structural cardiovascular abnormalities were identified in only 53 athletes (5%). Larger cardiac dimensions were associated with abnormal ECG patterns: left ventricular end-diastolic cavity dimensions were 56. 0+/-5.6, 55.4+/-5.7, and 53.7+/-5.7 mm (P<0.001) and maximum wall thicknesses were 10.1+/-1.4, 9.8+/-1.3, and 9.3+/-1.4 mm (P<0.001) in distinctly abnormal, mildly abnormal, and normal ECGs, respectively. Abnormal ECGs were also most associated with male sex, younger age (<20 years), and endurance sports (cycling, rowing/canoeing, and cross-country skiing). A subset of athletes (5% of the 1005) showed particularly abnormal or bizarre ECG patterns, but no evidence of structural cardiovascular abnormalities or an increase in cardiac dimensions. CONCLUSIONS-Most athletes (60%) in this large cohort had ECGs that were completely normal or showed only minor alterations. A variety of abnormal ECG patterns occurred in 40%; this was usually indicative of physiological cardiac remodeling. A small but important subgroup of athletes without cardiac morphological changes showed striking ECG abnormalities that suggested cardiovascular disease; however, these changes were likely an innocent consequence of long-term, intense athletic training and, therefore, another component of athlete heart syndrome. Such false-positive ECGs represent a potential limitation to routine ECG testing as part of preparticipation screening.

[1]  M. Sokolow,et al.  The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. , 1949, American heart journal.

[2]  A. Venerando,et al.  FREQUENCY MORPHOLOGY AND MEANING OF THE ELECTROCARDIOGRAPHIC ANOMALIES FOUND IN OLYMPIC MARATHON RUNNERS AND WALKERS. , 1964, The Journal of sports medicine and physical fitness.

[3]  K. Cullen,et al.  ELECTROCARDIOGRAMS OF MARATHON RUNNERS IN 1962 COMMONWEALTH GAMES , 1964, British heart journal.

[4]  D. Brunner,et al.  T wave abnormalities in the electrocardiograms of top-ranking athletes without demonstrable organic heart disease. , 1971, American heart journal.

[5]  H. Friedman Diagnostic electrocardiography and vectorcardiography , 1971 .

[6]  P. Armitage,et al.  Statistical methods in medical research. , 1972 .

[7]  R. O'rourke,et al.  Electrocardiogram of the athlete. Alterations simulating those of organic heart disease. , 1973, Archives of internal medicine.

[8]  R. O'rourke,et al.  Noninvasive Evaluation of Ventricular Hypertrophy in Professional Athletes , 1976, Circulation.

[9]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[10]  J. Ware,et al.  Echocardiographic Measurements in Normal Subjects from Infancy to Old Age , 1980, Circulation.

[11]  R. Fenici,et al.  T wave abnormalities in top-ranking athletes: effects of isoproterenol, atropine, and physical exercise. , 1980, American heart journal.

[12]  C. Oakley,et al.  Significance of abnormal electrocardiograms in highly trained athletes. , 1982, The American journal of cardiology.

[13]  B. Maron,et al.  Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. , 1983, The American journal of cardiology.

[14]  T. Ryan,et al.  Electrocardiogram of the athlete: an analysis of 289 professional football players. , 1984, The American journal of cardiology.

[15]  W. Rodney,et al.  The athletic heart syndrome. , 1985, The New England journal of medicine.

[16]  N. Ishikawa,et al.  Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. , 1986, The New England journal of medicine.

[17]  R. Devereux Detection of Left Ventricular Hypertrophy by M‐Mode Echocardiography: Anatomic Validation, Standardization, and Comparison to Other Methods , 1987, Hypertension.

[18]  R. Bonow,et al.  Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. , 1987, Journal of the American College of Cardiology.

[19]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[20]  N. Reichek,et al.  Electrocardiographic diagnosis of exercise-induced left ventricular hypertrophy. , 1988, American heart journal.

[21]  T. Meinertz,et al.  ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. , 1990, American heart journal.

[22]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[23]  B. Maron,et al.  Prospective echocardiographic screening for coronary artery anomalies in 1,360 elite competitive athletes. , 1993, The American journal of cardiology.

[24]  Clive Rosendorff,et al.  Autacoide und ihre Rolle in der Pathogenese der Husteninduktion durch Angiotensin-Konversionsenzym Hemmer , 1993 .

[25]  L. Storstein,et al.  Electrocardiographic and echocardiographic findings in top athletes, athletic students and sedentary controls. , 1993, Cardiology.

[26]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[27]  D. Levy,et al.  Gender-Specific Reference M-Mode Values in Adults: Population-Derived Values with Consideration of the Impact of Height , 1995, Journal of the American College of Cardiology.

[28]  B. Maron,et al.  Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.

[29]  B. Maron,et al.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. , 1995, Circulation.

[30]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[31]  B. Maron,et al.  Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. , 1996, JAMA.

[32]  D. Atkins,et al.  Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. , 1996, Circulation.

[33]  G. Whipple,et al.  Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. , 1997, Medicine and science in sports and exercise.

[34]  D. Corrado,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[35]  I. Ribeiro,et al.  Physiologic Left Ventricular Cavity Dilatation in Elite Athletes , 1999, Annals of Internal Medicine.

[36]  M. Sokolow,et al.  The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949. , 2001, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.